The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Albendazole Market Research Report 2025
Synopsis
Albendazole is a high-efficiency and low-toxic broad-spectrum anthelmintic drug. It was successfully developed and marketed by Skipper in the 1980s. It can be used clinically to ward off roundworms, pinworms, tapeworms, whipworms, hookworms, and anastomosis. After being metabolized to sulfoxides or sulfones in the body, it inhibits the parasite's absorption of glucose, leading to depletion of the body's glycogen, or inhibits the fumarate reductase system, hinders the production of ATP, and makes the parasite unable to survive and reproduce. Albendazole is a benzimidazole derivative, which is rapidly metabolized into sulfoxide, sulfone alcohol and 2-aminosulfone alcohol in the body, selectively and irreversibly inhibits the cytoplasmic microtubule system of intestinal wall cells of parasites Polymerization, blocking its uptake of various nutrients and glucose, leading to depletion of endogenous glycogen, and inhibiting the fumarate reductase system, preventing the production of adenosine triphosphate, making the worm unable to survive and reproduce. Similar to mebendazole, albendazole can also cause the degeneration of cytoplasmic microtubules in the intestinal cells of worms and bind to its tubulin, causing intracellular transport blockage, resulting in the accumulation of secretory particles in the Golgi body, the cytoplasm is gradually dissolved, and the cells are completely absorbed Denaturation causes death of the worm. Albendazole completely kills hookworm eggs and whipworm eggs and partially kills roundworm eggs. In addition to killing and repelling various nematodes parasitic in animals, it also has obvious killing and repelling effects on tapeworms and cysticercosis.
The global Albendazole market was valued at US$ 159.1 million in 2023 and is anticipated to reach US$ 270.8 million by 2030, witnessing a CAGR of 7.8% during the forecast period 2024-2030.
This is a relatively concentrated market, mainly due to the particularity of the pharmaceutical industry, where there are higher operating licenses and barriers, technical barriers, capital barriers and environmental barriers, so the concentration is higher. From the perspective of the global market, the original research firm GSK's albendazole accounts for more than 40% of the entire industry and is the leading enterprise in the albendazole industry. From the perspective of the Chinese market, the market concentration is also relatively high. The main companies are Huazhong Pharmaceutical and Jiangsu Qihui, which together account for 70% of the domestic market.
This report aims to provide a comprehensive presentation of the global market for Albendazole, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Albendazole.
Report Scope
The Albendazole market size, estimations, and forecasts are provided in terms of sales volume (K MT) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Albendazole market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Albendazole manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
GlaxoSmithKline
Huazhong Pharmaceutical
Jiangsu Qihui
Sequent Scientific
K.A. Malle Pharmaceuticals
Lasa Supergenerics Limited
Zhongjia Pharmaceutical
Fredun Pharmaceuticals Ltd
Supharma Chem
Salius Pharma
Segment by Type
Tablet
Capsule
Other
Segment by Application
Human
Veterinary
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Albendazole manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Albendazole in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Albendazole is a high-efficiency and low-toxic broad-spectrum anthelmintic drug. It was successfully developed and marketed by Skipper in the 1980s. It can be used clinically to ward off roundworms, pinworms, tapeworms, whipworms, hookworms, and anastomosis. After being metabolized to sulfoxides or sulfones in the body, it inhibits the parasite's absorption of glucose, leading to depletion of the body's glycogen, or inhibits the fumarate reductase system, hinders the production of ATP, and makes the parasite unable to survive and reproduce. Albendazole is a benzimidazole derivative, which is rapidly metabolized into sulfoxide, sulfone alcohol and 2-aminosulfone alcohol in the body, selectively and irreversibly inhibits the cytoplasmic microtubule system of intestinal wall cells of parasites Polymerization, blocking its uptake of various nutrients and glucose, leading to depletion of endogenous glycogen, and inhibiting the fumarate reductase system, preventing the production of adenosine triphosphate, making the worm unable to survive and reproduce. Similar to mebendazole, albendazole can also cause the degeneration of cytoplasmic microtubules in the intestinal cells of worms and bind to its tubulin, causing intracellular transport blockage, resulting in the accumulation of secretory particles in the Golgi body, the cytoplasm is gradually dissolved, and the cells are completely absorbed Denaturation causes death of the worm. Albendazole completely kills hookworm eggs and whipworm eggs and partially kills roundworm eggs. In addition to killing and repelling various nematodes parasitic in animals, it also has obvious killing and repelling effects on tapeworms and cysticercosis.
The global Albendazole market was valued at US$ 159.1 million in 2023 and is anticipated to reach US$ 270.8 million by 2030, witnessing a CAGR of 7.8% during the forecast period 2024-2030.
This is a relatively concentrated market, mainly due to the particularity of the pharmaceutical industry, where there are higher operating licenses and barriers, technical barriers, capital barriers and environmental barriers, so the concentration is higher. From the perspective of the global market, the original research firm GSK's albendazole accounts for more than 40% of the entire industry and is the leading enterprise in the albendazole industry. From the perspective of the Chinese market, the market concentration is also relatively high. The main companies are Huazhong Pharmaceutical and Jiangsu Qihui, which together account for 70% of the domestic market.
This report aims to provide a comprehensive presentation of the global market for Albendazole, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Albendazole.
Report Scope
The Albendazole market size, estimations, and forecasts are provided in terms of sales volume (K MT) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Albendazole market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Albendazole manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
GlaxoSmithKline
Huazhong Pharmaceutical
Jiangsu Qihui
Sequent Scientific
K.A. Malle Pharmaceuticals
Lasa Supergenerics Limited
Zhongjia Pharmaceutical
Fredun Pharmaceuticals Ltd
Supharma Chem
Salius Pharma
Segment by Type
Tablet
Capsule
Other
Segment by Application
Human
Veterinary
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Albendazole manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Albendazole in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Albendazole Market Overview
1.1 Product Overview and Scope of Albendazole
1.2 Albendazole Segment by Type
1.2.1 Global Albendazole Market Value Comparison by Type (2024-2030)
1.2.2 Tablet
1.2.3 Capsule
1.2.4 Other
1.3 Albendazole Segment by Application
1.3.1 Global Albendazole Market Value by Application: (2024-2030)
1.3.2 Human
1.3.3 Veterinary
1.4 Global Albendazole Market Size Estimates and Forecasts
1.4.1 Global Albendazole Revenue 2019-2030
1.4.2 Global Albendazole Sales 2019-2030
1.4.3 Global Albendazole Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Albendazole Market Competition by Manufacturers
2.1 Global Albendazole Sales Market Share by Manufacturers (2019-2024)
2.2 Global Albendazole Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Albendazole Average Price by Manufacturers (2019-2024)
2.4 Global Albendazole Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Albendazole, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Albendazole, Product Type & Application
2.7 Albendazole Market Competitive Situation and Trends
2.7.1 Albendazole Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Albendazole Players Market Share by Revenue
2.7.3 Global Albendazole Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Albendazole Retrospective Market Scenario by Region
3.1 Global Albendazole Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Albendazole Global Albendazole Sales by Region: 2019-2030
3.2.1 Global Albendazole Sales by Region: 2019-2024
3.2.2 Global Albendazole Sales by Region: 2025-2030
3.3 Global Albendazole Global Albendazole Revenue by Region: 2019-2030
3.3.1 Global Albendazole Revenue by Region: 2019-2024
3.3.2 Global Albendazole Revenue by Region: 2025-2030
3.4 North America Albendazole Market Facts & Figures by Country
3.4.1 North America Albendazole Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Albendazole Sales by Country (2019-2030)
3.4.3 North America Albendazole Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Albendazole Market Facts & Figures by Country
3.5.1 Europe Albendazole Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Albendazole Sales by Country (2019-2030)
3.5.3 Europe Albendazole Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Albendazole Market Facts & Figures by Country
3.6.1 Asia Pacific Albendazole Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Albendazole Sales by Country (2019-2030)
3.6.3 Asia Pacific Albendazole Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Albendazole Market Facts & Figures by Country
3.7.1 Latin America Albendazole Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Albendazole Sales by Country (2019-2030)
3.7.3 Latin America Albendazole Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Albendazole Market Facts & Figures by Country
3.8.1 Middle East and Africa Albendazole Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Albendazole Sales by Country (2019-2030)
3.8.3 Middle East and Africa Albendazole Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Albendazole Sales by Type (2019-2030)
4.1.1 Global Albendazole Sales by Type (2019-2024)
4.1.2 Global Albendazole Sales by Type (2025-2030)
4.1.3 Global Albendazole Sales Market Share by Type (2019-2030)
4.2 Global Albendazole Revenue by Type (2019-2030)
4.2.1 Global Albendazole Revenue by Type (2019-2024)
4.2.2 Global Albendazole Revenue by Type (2025-2030)
4.2.3 Global Albendazole Revenue Market Share by Type (2019-2030)
4.3 Global Albendazole Price by Type (2019-2030)
5 Segment by Application
5.1 Global Albendazole Sales by Application (2019-2030)
5.1.1 Global Albendazole Sales by Application (2019-2024)
5.1.2 Global Albendazole Sales by Application (2025-2030)
5.1.3 Global Albendazole Sales Market Share by Application (2019-2030)
5.2 Global Albendazole Revenue by Application (2019-2030)
5.2.1 Global Albendazole Revenue by Application (2019-2024)
5.2.2 Global Albendazole Revenue by Application (2025-2030)
5.2.3 Global Albendazole Revenue Market Share by Application (2019-2030)
5.3 Global Albendazole Price by Application (2019-2030)
6 Key Companies Profiled
6.1 GlaxoSmithKline
6.1.1 GlaxoSmithKline Corporation Information
6.1.2 GlaxoSmithKline Description and Business Overview
6.1.3 GlaxoSmithKline Albendazole Sales, Revenue and Gross Margin (2019-2024)
6.1.4 GlaxoSmithKline Albendazole Product Portfolio
6.1.5 GlaxoSmithKline Recent Developments/Updates
6.2 Huazhong Pharmaceutical
6.2.1 Huazhong Pharmaceutical Corporation Information
6.2.2 Huazhong Pharmaceutical Description and Business Overview
6.2.3 Huazhong Pharmaceutical Albendazole Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Huazhong Pharmaceutical Albendazole Product Portfolio
6.2.5 Huazhong Pharmaceutical Recent Developments/Updates
6.3 Jiangsu Qihui
6.3.1 Jiangsu Qihui Corporation Information
6.3.2 Jiangsu Qihui Description and Business Overview
6.3.3 Jiangsu Qihui Albendazole Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Jiangsu Qihui Albendazole Product Portfolio
6.3.5 Jiangsu Qihui Recent Developments/Updates
6.4 Sequent Scientific
6.4.1 Sequent Scientific Corporation Information
6.4.2 Sequent Scientific Description and Business Overview
6.4.3 Sequent Scientific Albendazole Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Sequent Scientific Albendazole Product Portfolio
6.4.5 Sequent Scientific Recent Developments/Updates
6.5 K.A. Malle Pharmaceuticals
6.5.1 K.A. Malle Pharmaceuticals Corporation Information
6.5.2 K.A. Malle Pharmaceuticals Description and Business Overview
6.5.3 K.A. Malle Pharmaceuticals Albendazole Sales, Revenue and Gross Margin (2019-2024)
6.5.4 K.A. Malle Pharmaceuticals Albendazole Product Portfolio
6.5.5 K.A. Malle Pharmaceuticals Recent Developments/Updates
6.6 Lasa Supergenerics Limited
6.6.1 Lasa Supergenerics Limited Corporation Information
6.6.2 Lasa Supergenerics Limited Description and Business Overview
6.6.3 Lasa Supergenerics Limited Albendazole Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Lasa Supergenerics Limited Albendazole Product Portfolio
6.6.5 Lasa Supergenerics Limited Recent Developments/Updates
6.7 Zhongjia Pharmaceutical
6.6.1 Zhongjia Pharmaceutical Corporation Information
6.6.2 Zhongjia Pharmaceutical Description and Business Overview
6.6.3 Zhongjia Pharmaceutical Albendazole Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Zhongjia Pharmaceutical Albendazole Product Portfolio
6.7.5 Zhongjia Pharmaceutical Recent Developments/Updates
6.8 Fredun Pharmaceuticals Ltd
6.8.1 Fredun Pharmaceuticals Ltd Corporation Information
6.8.2 Fredun Pharmaceuticals Ltd Description and Business Overview
6.8.3 Fredun Pharmaceuticals Ltd Albendazole Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Fredun Pharmaceuticals Ltd Albendazole Product Portfolio
6.8.5 Fredun Pharmaceuticals Ltd Recent Developments/Updates
6.9 Supharma Chem
6.9.1 Supharma Chem Corporation Information
6.9.2 Supharma Chem Description and Business Overview
6.9.3 Supharma Chem Albendazole Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Supharma Chem Albendazole Product Portfolio
6.9.5 Supharma Chem Recent Developments/Updates
6.10 Salius Pharma
6.10.1 Salius Pharma Corporation Information
6.10.2 Salius Pharma Description and Business Overview
6.10.3 Salius Pharma Albendazole Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Salius Pharma Albendazole Product Portfolio
6.10.5 Salius Pharma Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Albendazole Industry Chain Analysis
7.2 Albendazole Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Albendazole Production Mode & Process
7.4 Albendazole Sales and Marketing
7.4.1 Albendazole Sales Channels
7.4.2 Albendazole Distributors
7.5 Albendazole Customers
8 Albendazole Market Dynamics
8.1 Albendazole Industry Trends
8.2 Albendazole Market Drivers
8.3 Albendazole Market Challenges
8.4 Albendazole Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Albendazole Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Albendazole Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Albendazole Market Competitive Situation by Manufacturers in 2023
Table 4. Global Albendazole Sales (K MT) of Key Manufacturers (2019-2024)
Table 5. Global Albendazole Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Albendazole Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Albendazole Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Albendazole Average Price (USD/MT) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Albendazole, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Albendazole, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Albendazole, Product Type & Application
Table 12. Global Key Manufacturers of Albendazole, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Albendazole by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Albendazole as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Albendazole Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Albendazole Sales by Region (2019-2024) & (K MT)
Table 18. Global Albendazole Sales Market Share by Region (2019-2024)
Table 19. Global Albendazole Sales by Region (2025-2030) & (K MT)
Table 20. Global Albendazole Sales Market Share by Region (2025-2030)
Table 21. Global Albendazole Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Albendazole Revenue Market Share by Region (2019-2024)
Table 23. Global Albendazole Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Albendazole Revenue Market Share by Region (2025-2030)
Table 25. North America Albendazole Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Albendazole Sales by Country (2019-2024) & (K MT)
Table 27. North America Albendazole Sales by Country (2025-2030) & (K MT)
Table 28. North America Albendazole Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Albendazole Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Albendazole Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Albendazole Sales by Country (2019-2024) & (K MT)
Table 32. Europe Albendazole Sales by Country (2025-2030) & (K MT)
Table 33. Europe Albendazole Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Albendazole Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Albendazole Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Albendazole Sales by Region (2019-2024) & (K MT)
Table 37. Asia Pacific Albendazole Sales by Region (2025-2030) & (K MT)
Table 38. Asia Pacific Albendazole Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Albendazole Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Albendazole Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Albendazole Sales by Country (2019-2024) & (K MT)
Table 42. Latin America Albendazole Sales by Country (2025-2030) & (K MT)
Table 43. Latin America Albendazole Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Albendazole Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Albendazole Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Albendazole Sales by Country (2019-2024) & (K MT)
Table 47. Middle East & Africa Albendazole Sales by Country (2025-2030) & (K MT)
Table 48. Middle East & Africa Albendazole Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Albendazole Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Albendazole Sales (K MT) by Type (2019-2024)
Table 51. Global Albendazole Sales (K MT) by Type (2025-2030)
Table 52. Global Albendazole Sales Market Share by Type (2019-2024)
Table 53. Global Albendazole Sales Market Share by Type (2025-2030)
Table 54. Global Albendazole Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Albendazole Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Albendazole Revenue Market Share by Type (2019-2024)
Table 57. Global Albendazole Revenue Market Share by Type (2025-2030)
Table 58. Global Albendazole Price (USD/MT) by Type (2019-2024)
Table 59. Global Albendazole Price (USD/MT) by Type (2025-2030)
Table 60. Global Albendazole Sales (K MT) by Application (2019-2024)
Table 61. Global Albendazole Sales (K MT) by Application (2025-2030)
Table 62. Global Albendazole Sales Market Share by Application (2019-2024)
Table 63. Global Albendazole Sales Market Share by Application (2025-2030)
Table 64. Global Albendazole Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Albendazole Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Albendazole Revenue Market Share by Application (2019-2024)
Table 67. Global Albendazole Revenue Market Share by Application (2025-2030)
Table 68. Global Albendazole Price (USD/MT) by Application (2019-2024)
Table 69. Global Albendazole Price (USD/MT) by Application (2025-2030)
Table 70. GlaxoSmithKline Corporation Information
Table 71. GlaxoSmithKline Description and Business Overview
Table 72. GlaxoSmithKline Albendazole Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 73. GlaxoSmithKline Albendazole Product
Table 74. GlaxoSmithKline Recent Developments/Updates
Table 75. Huazhong Pharmaceutical Corporation Information
Table 76. Huazhong Pharmaceutical Description and Business Overview
Table 77. Huazhong Pharmaceutical Albendazole Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 78. Huazhong Pharmaceutical Albendazole Product
Table 79. Huazhong Pharmaceutical Recent Developments/Updates
Table 80. Jiangsu Qihui Corporation Information
Table 81. Jiangsu Qihui Description and Business Overview
Table 82. Jiangsu Qihui Albendazole Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 83. Jiangsu Qihui Albendazole Product
Table 84. Jiangsu Qihui Recent Developments/Updates
Table 85. Sequent Scientific Corporation Information
Table 86. Sequent Scientific Description and Business Overview
Table 87. Sequent Scientific Albendazole Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 88. Sequent Scientific Albendazole Product
Table 89. Sequent Scientific Recent Developments/Updates
Table 90. K.A. Malle Pharmaceuticals Corporation Information
Table 91. K.A. Malle Pharmaceuticals Description and Business Overview
Table 92. K.A. Malle Pharmaceuticals Albendazole Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 93. K.A. Malle Pharmaceuticals Albendazole Product
Table 94. K.A. Malle Pharmaceuticals Recent Developments/Updates
Table 95. Lasa Supergenerics Limited Corporation Information
Table 96. Lasa Supergenerics Limited Description and Business Overview
Table 97. Lasa Supergenerics Limited Albendazole Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 98. Lasa Supergenerics Limited Albendazole Product
Table 99. Lasa Supergenerics Limited Recent Developments/Updates
Table 100. Zhongjia Pharmaceutical Corporation Information
Table 101. Zhongjia Pharmaceutical Description and Business Overview
Table 102. Zhongjia Pharmaceutical Albendazole Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 103. Zhongjia Pharmaceutical Albendazole Product
Table 104. Zhongjia Pharmaceutical Recent Developments/Updates
Table 105. Fredun Pharmaceuticals Ltd Corporation Information
Table 106. Fredun Pharmaceuticals Ltd Description and Business Overview
Table 107. Fredun Pharmaceuticals Ltd Albendazole Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 108. Fredun Pharmaceuticals Ltd Albendazole Product
Table 109. Fredun Pharmaceuticals Ltd Recent Developments/Updates
Table 110. Supharma Chem Corporation Information
Table 111. Supharma Chem Description and Business Overview
Table 112. Supharma Chem Albendazole Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 113. Supharma Chem Albendazole Product
Table 114. Supharma Chem Recent Developments/Updates
Table 115. Salius Pharma Corporation Information
Table 116. Salius Pharma Description and Business Overview
Table 117. Salius Pharma Albendazole Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 118. Salius Pharma Albendazole Product
Table 119. Salius Pharma Recent Developments/Updates
Table 120. Key Raw Materials Lists
Table 121. Raw Materials Key Suppliers Lists
Table 122. Albendazole Distributors List
Table 123. Albendazole Customers List
Table 124. Albendazole Market Trends
Table 125. Albendazole Market Drivers
Table 126. Albendazole Market Challenges
Table 127. Albendazole Market Restraints
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Albendazole
Figure 2. Global Albendazole Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Albendazole Market Share by Type in 2023 & 2030
Figure 4. Tablet Product Picture
Figure 5. Capsule Product Picture
Figure 6. Other Product Picture
Figure 7. Global Albendazole Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 8. Global Albendazole Market Share by Application in 2023 & 2030
Figure 9. Human
Figure 10. Veterinary
Figure 11. Global Albendazole Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 12. Global Albendazole Market Size (2019-2030) & (US$ Million)
Figure 13. Global Albendazole Sales (2019-2030) & (K MT)
Figure 14. Global Albendazole Average Price (USD/MT) & (2019-2030)
Figure 15. Albendazole Report Years Considered
Figure 16. Albendazole Sales Share by Manufacturers in 2023
Figure 17. Global Albendazole Revenue Share by Manufacturers in 2023
Figure 18. The Global 5 and 10 Largest Albendazole Players: Market Share by Revenue in 2023
Figure 19. Albendazole Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 20. Global Albendazole Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 21. North America Albendazole Sales Market Share by Country (2019-2030)
Figure 22. North America Albendazole Revenue Market Share by Country (2019-2030)
Figure 23. U.S. Albendazole Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 24. Canada Albendazole Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Europe Albendazole Sales Market Share by Country (2019-2030)
Figure 26. Europe Albendazole Revenue Market Share by Country (2019-2030)
Figure 27. Germany Albendazole Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. France Albendazole Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. U.K. Albendazole Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. Italy Albendazole Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Russia Albendazole Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Asia Pacific Albendazole Sales Market Share by Region (2019-2030)
Figure 33. Asia Pacific Albendazole Revenue Market Share by Region (2019-2030)
Figure 34. China Albendazole Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. Japan Albendazole Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. South Korea Albendazole Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. India Albendazole Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. Australia Albendazole Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. China Taiwan Albendazole Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Indonesia Albendazole Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Thailand Albendazole Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Malaysia Albendazole Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Latin America Albendazole Sales Market Share by Country (2019-2030)
Figure 44. Latin America Albendazole Revenue Market Share by Country (2019-2030)
Figure 45. Mexico Albendazole Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Brazil Albendazole Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Argentina Albendazole Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Middle East & Africa Albendazole Sales Market Share by Country (2019-2030)
Figure 49. Middle East & Africa Albendazole Revenue Market Share by Country (2019-2030)
Figure 50. Turkey Albendazole Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. Saudi Arabia Albendazole Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. UAE Albendazole Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. Global Sales Market Share of Albendazole by Type (2019-2030)
Figure 54. Global Revenue Market Share of Albendazole by Type (2019-2030)
Figure 55. Global Albendazole Price (USD/MT) by Type (2019-2030)
Figure 56. Global Sales Market Share of Albendazole by Application (2019-2030)
Figure 57. Global Revenue Market Share of Albendazole by Application (2019-2030)
Figure 58. Global Albendazole Price (USD/MT) by Application (2019-2030)
Figure 59. Albendazole Value Chain
Figure 60. Albendazole Production Process
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Distributors Profiles
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
